HAIXI PHARMA (02637)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Li Junqing | 27-May-26 | ED | |||
| Lin Bin | 27-May-26 | INED, MbAC, MbStrC | |||
| Pu Meiting | 09-Oct-25 | ChAC, MbNC, MbCC | |||
| Wang Shan Shan | 09-Oct-25 | ChNC, ChCC, INED, MbAC | |||
| Kang Xinshan | 09-Oct-25 | ChStrC, MbNC, MbCC | |||
| Feng Yan | 09-Oct-25 | MbStrC | |||
| Pu Meiting | 01-Dec-24 | INED | |||
| Chen Guangming | 01-Oct-23 | Dep GM, ED | |||
| Zhang Junhuan | 01-Oct-21 | BrdSec, CFO | |||
| Feng Yan | 01-Nov-17 | Dep GM, ED | |||
| Kang Xinshan | 01-Mar-12 | Ch, GM, ED, Co-Fdr | |||
| Chen Shuyi | 01-Jul-22 | 27-May-26 | ED | Retired as Director after the conclusion of the AGM. | |
| Gong Weimin | 01-Oct-22 | 27-May-26 | INED | Retired as Director after the conclusion of the AGM. | |
| Lam Sophie Wai Yee | 21-Nov-25 | 06-Mar-26 | CoSec | Resignation. | |
| Lam Sophie Wai Yee | 06-Mar-26 | J-CoSec, Proc Agt | Resignation. | ||
| Chan Hiu Lam | 21-Nov-25 | J-CoSec, AuRep, Proc Agt | Resignation. |